These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7690087)

  • 41. Interaction of atenolol with the systemic and regional hemodynamic effects of hydralazine in conscious renal hypertensive rabbits.
    Bolt GR; Saxena PR
    J Pharmacol Exp Ther; 1984 Jul; 230(1):205-13. PubMed ID: 6747826
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Haemodynamic effects of atenolol and bopindolol at rest and during isometric exercise. A non-invasive study in healthy volunteers.
    Nieminen MS; Rapola J; Pellinen TJ; Toivonen L
    Ann Clin Res; 1988; 20(6):431-5. PubMed ID: 2905879
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Coronary vascular response to adrenergic stimulation in exercise-conditioned dogs.
    Gwirtz PA; Stone HL
    J Appl Physiol Respir Environ Exerc Physiol; 1984 Aug; 57(2):315-20. PubMed ID: 6469800
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of a new calcium antagonist, CD-832, on coronary and systemic hemodynamics in conscious dogs.
    Takahashi T; Tomoike H; Muramatsu K; Imamura Y; Narishige T; Takeshita A; Nakamura M
    J Cardiovasc Pharmacol; 1994 Jul; 24(1):8-12. PubMed ID: 7521495
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hemodynamic effects of pindolol and atenolol at rest and during isometric exercise: a noninvasive study with healthy volunteers.
    Rapola JM; Pellinen TJ; Koskinen P; Toivonen L; Nieminen MS
    Cardiovasc Drugs Ther; 1990 Jun; 4(3):737-43. PubMed ID: 2076384
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Beta 2-adrenergic dilation of conductance coronary arteries involves flow-dependent NO formation in conscious dogs.
    Hamdad N; Ming Z; Parent R; Lavallée M
    Am J Physiol; 1996 Nov; 271(5 Pt 2):H1926-37. PubMed ID: 8945911
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulation of large coronary arteries by beta-adrenergic mechanisms in the conscious dog.
    Vatner SF; Hintze TH; Macho P
    Circ Res; 1982 Jul; 51(1):56-66. PubMed ID: 6282497
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Celiprolol induces β(3)-adrenoceptors-dependent relaxation in isolated porcine coronary arteries.
    Abdelkrim MA; Martignat L; Gogny M; Desfontis JC; Noireaud J; Mallem MY
    Can J Physiol Pharmacol; 2013 Oct; 91(10):791-6. PubMed ID: 24144049
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulation of coronary blood flow during exercise.
    Duncker DJ; Bache RJ
    Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alpha-adrenergic vasoconstrictor tone limits right coronary blood flow in exercising dogs.
    Zong P; Sun W; Setty S; Tune JD; Downey HF
    Exp Biol Med (Maywood); 2004 Apr; 229(4):312-22. PubMed ID: 15044714
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of cocaine on the coronary circulation and systemic hemodynamics in dogs.
    Kuhn FE; Johnson MN; Gillis RA; Visner MS; Schaer GL
    J Am Coll Cardiol; 1990 Nov; 16(6):1481-91. PubMed ID: 2229802
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is there coronary vasoconstriction after intracoronary beta-adrenergic blockade in patients with coronary artery disease.
    Gaglione A; Hess OM; Corin WJ; Ritter M; Grimm J; Krayenbuehl HP
    J Am Coll Cardiol; 1987 Aug; 10(2):299-310. PubMed ID: 3110237
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiovascular effects of a novel calcium entry blocking and selective beta 1-adrenoceptor blocking agent, YM-16151-4, in anesthetized and conscious dogs.
    Uchida W; Shibasaki K; Asano M
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):60-8. PubMed ID: 1375689
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Coronary artery vasodilation in the canine: physiological and pharmacological roles of beta-adrenergic receptors.
    Jackson CV; Pope TK; Lucchesi BR
    J Cardiovasc Pharmacol; 1987 Aug; 10(2):196-204. PubMed ID: 2441171
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Intrinsic sympathomimetic action and its special features as demonstrated by the beta-1-receptor blocker celiprolol].
    Pittner H
    Wien Klin Wochenschr Suppl; 1985; 162():1-21. PubMed ID: 2861698
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potassium channel openers dilate large epicardial coronary arteries in conscious dogs by an indirect, endothelium-dependent mechanism.
    la Rochelle CD; Richard V; Dubois-Randé JL; Roupie E; Giudicelli JF; Hittinger L; Berdeaux A
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1091-6. PubMed ID: 1469622
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Celiprolol: a new beta adrenoceptor antagonist with novel ancillary properties.
    Pruss TP; Khandwala A; Wolf PS; Grebow P; Wong L
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S29-32. PubMed ID: 2427849
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of the haemodynamic effects of the selective bradycardic agent UL-FS 49, with those of propranolol during treadmill exercise in dogs.
    Krumpl G; Winkler M; Schneider W; Raberger G
    Br J Pharmacol; 1988 May; 94(1):55-64. PubMed ID: 3401644
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Partial agonist activity of celiprolol.
    Tung LH; Jackman G; Campbell B; Louis S; Iakovidis D; Louis WJ
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):484-8. PubMed ID: 7681512
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Celiprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cardiovascular disease.
    Milne RJ; Buckley MM
    Drugs; 1991 Jun; 41(6):941-69. PubMed ID: 1715268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.